Clinical Trial Results: LiveSMART Trial to Prevent Falls in Patients With Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 trial results for LiveSMART evaluating falls prevention in patients with cirrhosis and portal hypertension have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis of the Liver
• Portal Hypertension

Snippet

Sponsor: University of Michigan | Conditions: Cirrhosis, Liver, Portal Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2026-07-31